Software-Based Osteoporosis Detection System on Display with Leading
OEM Partners Including Fuji, SwissRay and CareStream Health
CompuMed, Inc. (OTCBB:CMPD) (www.compumed.net)
-- a medical informatics company serving the healthcare community with
diagnostic software solutions – is teaming up with key OEM partners to
showcase its OsteoGram® bone density imaging system this week
at the 94th Annual Meeting of the Radiological Society of
North America (RSNA) in Chicago.
The OsteoGram is on display with OEMs that have integrated the system
with their own industry leading applications. OsteoGram OEMs at RSNA
include CareStream Health (North Building – Hall B, Booth 8342),
FujiFilm Medical Systems (South Building – Hall A, Booth 4039) and
Swissray International (East Building – Hall D, Booth 1809).
The software-based OsteoGram system employs a patented imaging process
to measure bone density from a standard hand x-ray. It is compatible
with DICOM standards and has been shown in numerous clinical studies to
provide effective and accurate bone density measurement for screening
osteoporosis and assessing hip fracture risk. It has also demonstrated
significant cost advantages over other available screening technologies.
“We are delighted to team up with some of the most renowned names in
medical imaging to showcase the OsteoGram at RSNA,” said CompuMed CEO
Maurizio Vecchione.
The 2008 RSNA meeting is currently under way (November 30th –
December 4th) at Chicago’s McCormick Place. It is the world’s
largest medical conference and expo. This year’s meeting is expected to
be attended by more than 60,000 medical and scientific professionals
from around the globe.
More information about the OsteoGram is available from CompuMed’s
authorized OEM and distribution partners or by visiting www.CompuMed.net.
About CompuMed
CompuMed, Inc. (OTCBB:CMPD) develops and markets products and services
that combine advanced imaging with medical informatics. Its focus is on
analysis and remote monitoring for patients with cardiovascular and
musculoskeletal diseases. The Company has specialized expertise and
intellectual property in telemonitoring imaging and analysis designed to
improve healthcare provider workflow and patient care while reducing
costs. CompuMed's core products, the OsteoGram(R) and CardioGram(TM),
are cleared by the FDA and reimbursable by Medicare.